BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
5/25/2022 8:33:35 AM | Browse: 386 | Download: 769
 |
Received |
|
2021-11-10 12:28 |
 |
Peer-Review Started |
|
2021-11-10 12:29 |
 |
To Make the First Decision |
|
|
 |
Return for Revision |
|
2022-01-10 12:49 |
 |
Revised |
|
2022-01-17 14:36 |
 |
Second Decision |
|
2022-04-28 03:28 |
 |
Accepted by Journal Editor-in-Chief |
|
|
 |
Accepted by Executive Editor-in-Chief |
|
2022-04-28 20:48 |
 |
Articles in Press |
|
2022-04-28 20:48 |
 |
Publication Fee Transferred |
|
|
 |
Edit the Manuscript by Language Editor |
|
2022-03-30 01:57 |
 |
Typeset the Manuscript |
|
2022-05-11 02:24 |
 |
Publish the Manuscript Online |
|
2022-05-25 08:33 |
ISSN |
1948-9366 (online) |
Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
Copyright |
©The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved. |
Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
Website |
http://www.wjgnet.com |
Category |
Oncology |
Manuscript Type |
Review |
Article Title |
Recent advances in diagnosis and treatment of gastroenteropancreatic neuroendocrine neoplasms
|
Manuscript Source |
Invited Manuscript |
All Author List |
Meng Dai, Christina S Mullins, Lili Lu, Guido Alsfasser and Michael Linnebacher |
ORCID |
|
Funding Agency and Grant Number |
Funding Agency |
Grant Number |
China Scholarship Council |
202108080085 |
China Scholarship Council |
201908080127 |
|
Corresponding Author |
Michael Linnebacher, PhD, Academic Fellow, Research Fellow, Research Scientist, Senior Researcher, Senior Scientist, Department of General, Visceral, Thoracic, Vascular and Transplantation Surgery, Molecular Oncology and Immunotherapy, University Medical Center Rostock, Schillingallee 35, Rostock 18057, Mecklenburg-Vorpommern, Germany. michael.linnebacher@med.uni-rostock.de |
Key Words |
Gastroenteropancreatic neuroendocrine neoplasms; Functional imaging; Peptide receptor radionuclide therapy; Targeting agents; Immune checkpoint inhibitors; Genetic mutations |
Core Tip |
Gastroenteropancreatic neuroendocrine neoplasms (GEP-NENs) are a group of heterogeneous tumors arising from neuroendocrine cells of the digestive system. Researchers have achieved great improvements in diagnosis and treatment. This includes improved grading, identification of specific genetic mutations, functional imaging, and broad application of peptide receptor radionuclide therapy. We here systematically summarized the latest progress in diagnosis and treatment of GEP-NENs, thereby providing guidance for clinicians active in this field. |
Publish Date |
2022-05-25 08:33 |
Citation |
Dai M, Mullins CS, Lu L, Alsfasser G, Linnebacher M. Recent advances in diagnosis and treatment of gastroenteropancreatic neuroendocrine neoplasms. World J Gastrointest Surg 2022; 14(5): 383-396 |
URL |
https://www.wjgnet.com/1948-9366/full/v14/i5/383.htm |
DOI |
https://dx.doi.org/10.4240/wjgs.v14.i5.383 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345